Merrimack Pharmaceuticals Inc (MACK)
14.68
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
14.68
0.00 (0.00%)
After-Hours: 20:00
Merrimack Pharmaceuticals Market Cap: 213.33M for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 213.33M |
| April 17, 2024 | 213.33M |
| April 16, 2024 | 213.33M |
| April 15, 2024 | 213.33M |
| April 12, 2024 | 213.33M |
| April 11, 2024 | 214.05M |
| April 10, 2024 | 213.91M |
| April 09, 2024 | 214.05M |
| April 08, 2024 | 213.62M |
| April 05, 2024 | 213.76M |
| April 04, 2024 | 213.62M |
| April 03, 2024 | 213.76M |
| April 02, 2024 | 214.05M |
| April 01, 2024 | 214.20M |
| March 28, 2024 | 214.63M |
| March 27, 2024 | 214.34M |
| March 26, 2024 | 213.91M |
| March 25, 2024 | 214.05M |
| March 22, 2024 | 214.93M |
| March 21, 2024 | 213.47M |
| March 20, 2024 | 213.47M |
| March 19, 2024 | 213.47M |
| March 18, 2024 | 213.91M |
| March 15, 2024 | 214.20M |
| March 14, 2024 | 212.81M |
| Date | Value |
|---|---|
| March 13, 2024 | 213.24M |
| March 12, 2024 | 212.66M |
| March 11, 2024 | 212.81M |
| March 08, 2024 | 213.68M |
| March 07, 2024 | 214.40M |
| March 06, 2024 | 213.53M |
| March 05, 2024 | 213.24M |
| March 04, 2024 | 210.82M |
| March 01, 2024 | 211.53M |
| February 29, 2024 | 210.96M |
| February 28, 2024 | 210.96M |
| February 27, 2024 | 211.10M |
| February 26, 2024 | 210.96M |
| February 23, 2024 | 211.39M |
| February 22, 2024 | 211.25M |
| February 21, 2024 | 210.67M |
| February 20, 2024 | 210.96M |
| February 16, 2024 | 210.96M |
| February 15, 2024 | 210.96M |
| February 14, 2024 | 210.53M |
| February 13, 2024 | 215.26M |
| February 12, 2024 | 200.77M |
| February 09, 2024 | 198.04M |
| February 08, 2024 | 195.46M |
| February 07, 2024 | 187.42M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
21.81M
Minimum
Mar 20 2020
215.26M
Maximum
Feb 13 2024
98.62M
Average
79.92M
Median
Jun 27 2022
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.528M |
| Palatin Technologies Inc | 30.50M |
| iBio Inc | 6.167M |
| Theriva Biologics Inc | 7.682M |
| Ampio Pharmaceuticals Inc | 0.2748M |
Market Cap Related Metrics
| PS Ratio | 209909.3 |
| PEG Ratio | -0.0171 |
| Price to Book Value | 11.38 |
| Price | 14.68 |
| Earnings Yield | -0.54% |
| PEGY Ratio | -0.0171 |